Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 25, 2018 12:53 ET | Source: Qu Biologics

Qu Biologics enrolls the first patient in new Phase 2 Crohn’s Disease clinical trial

VANCOUVER, British Columbia, July 25, 2018 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies...
October 03, 2017 12:16 ET | Source: Qu Biologics

Response to Novel Immune Therapy for Ulcerative Colitis Associated with Genetic and Immune Biomarkers

VANCOUVER, British Columbia , Oct. 03, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...